Please login to the form below

Not currently logged in


This page shows the latest BARDA news and features for those working in and with pharma, biotech and healthcare.

EU concludes discussions with Moderna for COVID-19 vaccine

EU concludes discussions with Moderna for COVID-19 vaccine

We are advancing the clinical development of mRNA-1273 with the ongoing phase 3 study being conducted in collaboration with NIAID and BARDA.

Latest news

More from news
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    That includes an agreement with the US Biomedical Advanced Research and Development Authority (BARDA) on the development of a recombinant, protein-based vaccine candidate.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    US agencies like BARDA have a long history of supporting these innovative approaches to public health. ... We are conducting a 134-person influenza challenge study, one of the largest ever conducted and co-funded by BARDA,  to validate this approach.

  • Deal Watch September 2016 Deal Watch September 2016

    BARDA) has been very busy announcing grants with a range of companies for various development projects. ... The Medicines Co received a BARDA grant of up to $132m for the development of antibiotics against drug-resistant, gram-negative infections.

  • Deal Watch June 2016 Deal Watch June 2016

    BARDA) to support Cerus' clinical development programme for pathogen reduction of red blood cell (RBC) components. ... collaboration, licence. 200. Cerus/ BARDA. Intercept, pathogen reduction technology for blood transfusions including Zika virus.

  • Pharma deals during May 2013 Pharma deals during May 2013

    infectives. The latest example is the agreement between BARDA, part of the US Department of Health, and GSK worth up to $200m to develop new antibiotics.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...